These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 731812)

  • 41. Urinary calcium and magnesium variations during sodium cellulose phosphate treatment.
    Trinchieri A; Mandressi A; Zanetti G; Patelli E; Donghi G; Rocco F
    Contrib Nephrol; 1984; 37():41-4. PubMed ID: 6713878
    [No Abstract]   [Full Text] [Related]  

  • 42. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reduction of urinary oxalate by combined calcium and citrate administration without increase in urinary calcium oxalate stone formers.
    Ito H; Suzuki F; Yamaguchi K; Nishikawa Y; Kotake T
    Clin Nephrol; 1992 Jan; 37(1):14-8. PubMed ID: 1541059
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Idiopathic hypercalciuria in calcium nephrolithiasis.
    Coe FL; Favus MJ
    Dis Mon; 1980 Sep; 26(12):1-36. PubMed ID: 6905773
    [No Abstract]   [Full Text] [Related]  

  • 45. The variability and dietary dependence of urinary oxalate excretion in recurrent calcium stone formers.
    Brown JM; Stratmann G; Cowley DM; Mottram BM; Chalmers AH
    Ann Clin Biochem; 1987 Jul; 24 ( Pt 4)():385-90. PubMed ID: 3662388
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Determinants of calcium and oxalate excretion in subjects with calcium nephrolithiasis: the role of metabolic syndrome traits.
    Ticinesi A; Guerra A; Allegri F; Nouvenne A; Cervellin G; Maggio M; Lauretani F; Borghi L; Meschi T
    J Nephrol; 2018 Jun; 31(3):395-403. PubMed ID: 29090382
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Investigation and treatment of renal calculi associated with hypercalciuria.
    Holdaway IM; Evans MC; Frengley PA; Ibbertson HK
    J Endocrinol Invest; 1982; 5(6):361-5. PubMed ID: 6302159
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of nifedipine on urinary calcium and oxalate excretion in renal stone formers.
    Baggio B; Gambaro G; Marchini F; Cicerello E; Borsatti A
    Nephron; 1986; 43(3):234-5. PubMed ID: 3724934
    [No Abstract]   [Full Text] [Related]  

  • 49. The role of oxalate and calcium oxalate activity and formation product ratio in patients with renal stones before and during treatment.
    Peña JC; Monforte MF; Briceño A
    J Urol; 1987 Nov; 138(5):1137-40. PubMed ID: 3669156
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dietary protein levels affect the excretion of oxalate and calcium in patients with absorptive hypercalciuria type II.
    Urivetzky M; Motola J; Braverman S; Smith AD
    J Urol; 1987 Apr; 137(4):690-2. PubMed ID: 3560323
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men.
    Curhan GC; Willett WC; Speizer FE; Stampfer MJ
    Kidney Int; 2001 Jun; 59(6):2290-8. PubMed ID: 11380833
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Designer probiotic Lactobacillus plantarum expressing oxalate decarboxylase developed using group II intron degrades intestinal oxalate in hyperoxaluric rats.
    Paul E; Albert A; Ponnusamy S; Mishra SR; Vignesh AG; Sivakumar SM; Sivasamy G; Sadasivam SG
    Microbiol Res; 2018 Oct; 215():65-75. PubMed ID: 30172310
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of patients with calcium-containing renal stones with cellulose phosphate.
    Pietrek J; Kokot F
    Br J Urol; 1973 Apr; 45(2):136-43. PubMed ID: 4706494
    [No Abstract]   [Full Text] [Related]  

  • 54. An approach to dissolving kidney calculi by ion exchange reaction in aqueous media.
    Nishino T; Sakurai T; Sato T; Koiso K; Kaneko S
    Nihon Jinzo Gakkai Shi; 1987 May; 29(5):571-5. PubMed ID: 2821303
    [No Abstract]   [Full Text] [Related]  

  • 55. [Hypercalciuria and primary hyperparathyroidism in patients with kidney calculi. I. Hypercalciuria].
    Nieszporek T; Kokot F; Skrzypek J; Wieczorek M; Kuska J
    Pol Arch Med Wewn; 1992 Jan; 87(1):41-8. PubMed ID: 1641363
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Idiopathic calcium oxalate urinary lithiasis: new physiopathological approaches].
    Berland Y
    Nephrologie; 1999; 20(7):363-9. PubMed ID: 10642984
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Mechanism of lithogenesis. VIII. Effect of DEAE-cellulose in absorptive hyperoxaluria].
    Pinto B; Bernshtam J
    Rev Clin Esp; 1978 Jan; 148(1):65-8. PubMed ID: 635255
    [No Abstract]   [Full Text] [Related]  

  • 58. Urinary outputs of oxalate, calcium, and magnesium in children with intestinal disorders. Potential cause of renal calculi.
    Ogilvie D; McCollum JP; Packer S; Manning J; Oyesiku J; Muller DP; Harries JT
    Arch Dis Child; 1976 Oct; 51(10):790-5. PubMed ID: 1008583
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Graphic display of urinary risk factors for renal stone formation.
    Pak CY; Skurla C; Harvey J
    J Urol; 1985 Nov; 134(5):867-70. PubMed ID: 4057368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.